CervoMed Inc. Common Stock
XNAS:CRVO
9.94
$11.99 - 113.00
$2.25 - 5.00
$9.41
$10
$9.98
$9.94
16.94
1.8
69970
104119
4789689.01
Chart
TendieTensor AI Analysis
Company
CervoMed Inc is a clinical stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.
Fundamentals
15
-3.430000
3.535830
-0.84
100
BBG000N6JH48
BBG001SD4Z42
9.25M
9.25M
Technicals
Short Interest
—
—
—
Higher = harder to cover
—
Prev: —
—
—
5D avg: —
—
Discussion
Login to participate in discussions.
Recent News
Related Stocks
Based on the portfolios of people who own CRVO. This is a list generated by trading data from 3rd party trading platforms, and it's not a recommendation.